VR
Vishakh Ramrao Kharat
About Vishakh Ramrao Kharat
Data last updated:
Vishakh Ramrao Kharat is a Director at Neovant Therapeutics Private Limited (since 2023). The company operates in Pharma. Neovant Therapeutics Private Limited reported revenue of ₹2.66 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Dec 2023 | 2023 | ₹2.66 Cr (FY 2025) | Active |
Board colleagues of Vishakh Ramrao Kharat
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dashrathbhai Kalidas Patel | 00155539 | Neovant Therapeutics Private Limited | Director |
| Dilip Shankarbhai Chaudhary | 01354482 | Neovant Therapeutics Private Limited | Director |
| Jagdish Madhavlal Chaudhary | 01687830 | Neovant Therapeutics Private Limited | Director |
| Nirav Pravinkumar Trivedi | 07305698 | Neovant Therapeutics Private Limited | Director |
| Patwa Anmol Ajaybhai | 06749808 | Neovant Therapeutics Private Limited | Director |
| Ramakrishna Guduru | 09464093 | Neovant Therapeutics Private Limited | Director |
| Umesh Vinayakrao Barabde | 10347239 | Neovant Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vishakh Ramrao Kharat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vishakh Ramrao Kharat
Vishakh Ramrao Kharat currently holds 1 directorship: Neovant Therapeutics Private Limited (Director, since 01 Dec 2023, revenue ₹2.66 Cr (FY 2025)).
Vishakh Ramrao Kharat was first appointed on 01 Dec 2023 as Director at Neovant Therapeutics Private Limited.
The current boards of Vishakh Ramrao Kharat's companies include Dashrathbhai Kalidas Patel (Neovant Therapeutics Private Limited), Dilip Shankarbhai Chaudhary (Neovant Therapeutics Private Limited), Jagdish Madhavlal Chaudhary (Neovant Therapeutics Private Limited), Nirav Pravinkumar Trivedi (Neovant Therapeutics Private Limited), Patwa Anmol Ajaybhai (Neovant Therapeutics Private Limited), Ramakrishna Guduru (Neovant Therapeutics Private Limited), among others.